Shengnan Cui Selected Research

Shengnan Cui Research Topics

4	Wounds and Injuries (Trauma) 05/2024 - 01/2023
3	Inflammation (Inflammations) 01/2023 - 01/2022
2	Hematologic Diseases (Blood Diseases) 12/2023 - 01/2023
2	Melanoma (Melanoma, Malignant) 01/2022 - 06/2019
1	Thyroid Diseases (Thyroid Disease) 12/2023
1	Cicatrix (Scar) 09/2023
1	Hypertrophic Cicatrix (Hypertrophic Scar) 09/2023
1	Neoplasms (Cancer) 07/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2023
1	Leukocytosis (Pleocytosis) 01/2022
1	Insulin Resistance 01/2021
1	Lipodystrophy 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021

3	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2019
2	Glucose (Dextrose)FDA LinkGeneric 09/2023 - 01/2021
2	CytokinesIBA 01/2023 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 06/2019
1	Circular RNAIBA 05/2024
1	Streptozocin (Streptozotocin)FDA Link 05/2024
1	Prealbumin (Transthyretin)IBA 12/2023
1	MicroRNAs (MicroRNA)IBA 09/2023
1	HydrogelsIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	gelatin methacryloylIBA 01/2023
1	Biocompatible Materials (Biomaterials)IBA 01/2023
1	CollagenIBA 01/2023
1	spleen fibrinolytic proteinase (human) (SFP)IBA 01/2023
1	EpitopesIBA 01/2023
1	AutoantibodiesIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	SteroidsIBA 01/2022
1	Oligoclonal BandsIBA 01/2022
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	AMP-Activated Protein KinasesIBA 01/2021
1	LipidsIBA 01/2021

1	Subcutaneous Injections 05/2024
1	Renal Replacement Therapy (Therapies, Renal Replacement) 07/2023